Enantioselective inhibition of d-serine transport by (S)-ketamine.

Br J Pharmacol

Laboratory of Clinical Investigation, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

Published: September 2015

AI Article Synopsis

  • (R,S)-Ketamine treatment in patients with major depressive disorder leads to increased dissociative symptoms and reduced plasma d-serine levels, suggesting a pharmacological effect on d-serine concentrations.
  • (S)-Ketamine enhances intracellular d-serine while lowering its levels outside the cell, whereas (R)-ketamine decreases both intracellular and extracellular d-serine concentrations.
  • The study indicates that (S)-ketamine acts by inhibiting the ASCT2 transporter, which regulates d-serine levels, and may influence the expression of serine racemase across different cell types.

Article Abstract

Background And Purpose: Patients with major depressive disorder receiving racemic ketamine, (R,S)-ketamine, experience transient increases in Clinician-Administered Dissociative States Scale scores and a coincident drop in plasma d-serine levels. The results suggest that (R,S)-ketamine produces an immediate, concentration-dependent pharmacological effect on d-serine plasma concentrations. One potential source of this effect is (R,S)-ketamine-induced inhibition of the transporter ASCT2, which regulates intracellular d-serine concentrations. In this study, we tested this hypothesis by examining the effect of (S)- and (R)-ketamine on ASCT2-mediated transport of d-serine in PC-12 and 1321N1 cells and primary neuronal cells in culture.

Experimental Approach: Intracellular and extracellular d-serine levels were determined using capillary electrophoresis-laser-induced fluorescence and liquid chromatography-mass spectrometry respectively. Expression of ASCT2, Asc-1 and serine racemase was determined utilizing Western blotting.

Key Results: (S)-Ketamine produced a concentration-dependent increase in intracellular d-serine and reduced extracellular d-serine accumulation. In contrast, (R)-ketamine decreased both intracellular and extracellular d-serine levels. The ASCT2 inhibitor, benzyl-d-serine (BDS), and ASCT2 gene knockdown mimicked the action of (S)-ketamine on d-serine in PC-12 cells, while the Asc-1 agonist d-isoleucine reduced intracellular d-serine and increased extracellular d-serine accumulation. This response to d-isoleucine was not affected by BDS or (S)-ketamine. Primary cultures of rat neuronal cells expressed ASCT2 and were responsive to (S)-ketamine and BDS. (S)- and (R)-ketamine increased the expression of monomeric serine racemase in all the cells studied, with (S)-ketamine having the greatest effect.

Conclusions And Implications: (S)-Ketamine decreased cellular export of d-serine via selective inhibition of ASCT2, and this could represent a possible source of dissociative effects observed with (R,S)-ketamine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562514PMC
http://dx.doi.org/10.1111/bph.13239DOI Listing

Publication Analysis

Top Keywords

extracellular d-serine
16
d-serine
13
d-serine levels
12
intracellular d-serine
12
d-serine pc-12
8
neuronal cells
8
intracellular extracellular
8
serine racemase
8
d-serine accumulation
8
s-ketamine
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!